195 related articles for article (PubMed ID: 26583478)
1. Generic Preference-based Measures for Low Back Pain: Which of Them Should Be Used?
Finch AP; Dritsaki M; Jommi C
Spine (Phila Pa 1976); 2016 Mar; 41(6):E364-74. PubMed ID: 26583478
[TBL] [Abstract][Full Text] [Related]
2. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
3. A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain.
Ye Z; Sun L; Wang Q
Health Qual Life Outcomes; 2019 Apr; 17(1):57. PubMed ID: 30971265
[TBL] [Abstract][Full Text] [Related]
4. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
5. Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments.
Suarez-Almazor ME; Kendall C; Johnson JA; Skeith K; Vincent D
Rheumatology (Oxford); 2000 Jul; 39(7):783-90. PubMed ID: 10908699
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the correlation and responsiveness of patient-reported pain with function and quality-of-life outcomes after spine surgery.
DeVine J; Norvell DC; Ecker E; Fourney DR; Vaccaro A; Wang J; Andersson G
Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S69-74. PubMed ID: 21897347
[TBL] [Abstract][Full Text] [Related]
7. Mapping between the Roland Morris Questionnaire and generic preference-based measures.
Khan KA; Madan J; Petrou S; Lamb SE
Value Health; 2014 Sep; 17(6):686-95. PubMed ID: 25236992
[TBL] [Abstract][Full Text] [Related]
8. Evidence on the measurement properties of health-related quality of life instruments is largely missing in patients with low back pain: A systematic review.
Chiarotto A; Terwee CB; Kamper SJ; Boers M; Ostelo RW
J Clin Epidemiol; 2018 Oct; 102():23-37. PubMed ID: 29793009
[TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
[TBL] [Abstract][Full Text] [Related]
10. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
[TBL] [Abstract][Full Text] [Related]
11. Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D.
Mulhern B; Pink J; Rowen D; Borghs S; Butt T; Hughes D; Marson A; Brazier J
Value Health; 2017 Apr; 20(4):687-693. PubMed ID: 28408012
[TBL] [Abstract][Full Text] [Related]
12. Evaluating common outcomes for measuring treatment success for chronic low back pain.
Chapman JR; Norvell DC; Hermsmeyer JT; Bransford RJ; DeVine J; McGirt MJ; Lee MJ
Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S54-68. PubMed ID: 21952190
[TBL] [Abstract][Full Text] [Related]
13. A review of preference-based health-related quality of life questionnaires in spinal cord injury research.
Whitehurst DG; Noonan VK; Dvorak MF; Bryan S
Spinal Cord; 2012 Sep; 50(9):646-54. PubMed ID: 22641255
[TBL] [Abstract][Full Text] [Related]
14. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.
Xin Y; McIntosh E
Qual Life Res; 2017 Jan; 26(1):1-23. PubMed ID: 27778141
[TBL] [Abstract][Full Text] [Related]
16. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
[TBL] [Abstract][Full Text] [Related]
17. Comparison of EQ-5D and SF-6D utilities in Pompe disease.
Kanters TA; Redekop WK; Kruijshaar ME; van der Ploeg AT; Rutten-van Mölken MP; Hakkaart L
Qual Life Res; 2015 Apr; 24(4):837-44. PubMed ID: 25342117
[TBL] [Abstract][Full Text] [Related]
18. A review of preference-based measures for the assessment of quality of life in children and adolescents with cerebral palsy.
Mpundu-Kaambwa C; Chen G; Huynh E; Russo R; Ratcliffe J
Qual Life Res; 2018 Jul; 27(7):1781-1799. PubMed ID: 29569017
[TBL] [Abstract][Full Text] [Related]
19. An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment.
Yang Y; Longworth L; Brazier J
Qual Life Res; 2013 Dec; 22(10):2813-28. PubMed ID: 23709096
[TBL] [Abstract][Full Text] [Related]
20. How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review.
Papaioannou D; Brazier J; Parry G
Value Health; 2011; 14(6):907-20. PubMed ID: 21914513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
